Related Experiment Video
Updated: Apr 12, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Development and validation of a nomogram to estimate the risk of prostate cancer in Brazil
Thiago B Silva1, Cleyton Z Oliveira2, Eliney F Faria3
1Department of Cancer Prevention, Barretos Cancer Hospital, Barretos, SP, Brazil tbuosi@gmail.com.
Aim:
To develop and validate a nomogram to estimate the probability of prostate cancer (PCa) in men undergoing opportunistic screening.
Patients And Methods:
This was a cross-sectional observational study on a cohort of men screened for PCa at the Barretos Cancer Hospital (BCH) between January 2004 and December 2007. Patients' data were collected from their charts and binary logistic regression analyses were performed to assess the power of various factor combinations as predictors of the PCa risk.
Results:
Out of the 1,313 screened men who underwent prostate biopsy, 553 (42.1%) had histopathological confirmation of PCa. The logistic regression analyses provided an area under the receiver operating characteristics (ROC) curve (AUC) of 0.737 (95% confidence interval (CI)=0.678-0.796) for the best predictor combination. A nomogram was constructed to estimate the individual risk for PCa prior to biopsy.
Conclusion:
Our nomogram provides an easy and practical method, superior in performance to the traditional criteria, predicting the diagnosis of PCa with a reasonable accuracy.
Related Concept Videos
Dosage Regimen Designs: Nomograms and Tabulations
Relative Risk
Cancer Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

